Xarelto - A High-Risk Treatment Causing Uncontrollable Bleeding

Xarelto (Rivaroxaban) is a once-a- day blood thinner prescription to prevent blood clots.. The Food and Drug Administration (FDA) approved Xarelto for use in patients who have had knee or hip replacement surgery to reduce the risk of blood clots, reduce the risk of stroke and as a general treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Xarelto, however, has been reported to cause uncontrollable bleeding that can lead to hospitalization and death. When bleeding occurs near a major organ, such as the brain, lungs or kidneys, it could cause it the organ to lose some or all of its functionality. Also, pools of blood may form within the body and can cause other severe health risks. Because Xarelto prevents clotting, the hemorrhaging will continue until the drug is flushed out of the system.

A study done by the British Medical Journal (BMJ), shows Xarelto is associated with a significant increase in risk of clinically relevant bleeding (relative risk 1.25, 95% confidence interval 1.05 to 1.49; P=0.01) The study also indicates that Xarelto will cause more major bleeding over all other outcomes among other warfarin alternatives.

Bayer and Johnson and Johnson’s subsidiary, Janssen Pharmaceuticals, market Xarelto the as providing the same or slightly better results than warfarin in preventing strokes and other blood clot-related events, despite the fact there is no known antidote that currently exists to reverse internal bleeding. Patients are spending about $3000 per year for Xarelto compared to $200 per year for warfarin and the drug does not require regular blood tests or monitoring. (http://www.drugwatch.com/xarelto/) Also, unlike older anticoagulants that require doctors to prescribe specific doses for each individual, Xarelto belongs to a new type of oral anticoagulant that is prescribed in one uniform dose.

Some of Americas top heart doctors are concerned about Xarelto’s safety along with the financial hardship caused by emergency visits, ongoing care, and lost wages, emotion distress, increasing deaths linked to uncontrolled bleeding caused by Xarelto and holding Bayer and Janssen Pharmaceuticals accountable for releasing a dangerous drug. By the end of the 2012, the U.S. Food & Drug Administration (FDA) has received 2,081 reports of Xarelto complications, including 151 that resulted in death. (http://www.bio-medicine.org/medicine-news-1/Xarelto-Lawsuit-Alleges-Uncontrollable-Bleeding-Nearly-Cost-California-Woman-Her-Life--Bernstein-Liebhard-LLP-Reports-134127-2/)

A letter issued to the director of Johnson & Johnson from the FDA, Center for Drug Evaluation and Research, Office of Prescription Drug Promotion stated Xarelto’s print ad in the 2013 WebMD magazine, as false or misleading because it minimizes the risks associated with Xarelto and makes a misleading claim. The risk information was presented on the adjacent page without any emphasis, which fails to convey the risk information without reasonable readability comparable to the efficacy claims.

Read more at:

http://blogs.wsj.com/pharmalot/2014/08/29/the-clot-thickens-lawyers-boost-spending-to-solicit-xarelto-lawsuits/

http://freepdfhosting.com/ebda6846b5.pdf

http://www.drugwatch.com/xarelto/lawsuit/

BMJ 2012;344:e3675 doi: 10.1136/bmj.e3675 (Published 14 June 2012)http://www.ncbi.nlm.nih.gov/pubmed/22700784

http://www.fda.gov/Safety/MedWatch/HowToReport/DownloadForms/default.htm

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation....

Categories

    Attorney Tor and the whole team at Spangenberg Shibley & Liber, including the receptionist, made me feel welcome, comforted, and confident throughout my case. They showed me respect and kindness from start to finish.

    - Zandra S.

    I was feeling uncertain but after I met with Nick I felt at ease & confident. Communication was great, I was constantly informed and everyone was genuine & compassionate.

    - Sonja S.

    Coming in, we were unsure if we had a case. After meeting with Peter Brodhead, we were very confident with him. I was always comfortable because everyone was professional and friendly.

    - Elaine B.

    I liked the professionalism, efficiency, and thoroughness of your team efforts. I would like Sheila Schebek recognized for her knowledge of account details as quickly as I presented questions. She provided confidence and security in all matters.

    - John S.

    Before I called you, I felt awful & depressed when I heard about cancer. After I called you and discussed, I felt better knowing that this law firm cared for me. They were very kind and well communicated with me.

    - Gary S.
/

Put Award-Winning
Trial Lawyers On Your Side

Contact Our Team for a Free & Confidential Case Evaluation
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.